ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.
about
Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic DataEndothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK ActivationNonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilizationDai-Huang-Fu-Zi-Tang alleviates pulmonary and intestinal injury with severe acute pancreatitis via regulating aquaporins in rats.Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens.Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodelingRole of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1s down-regulation.Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction.Stiffness-activated GEF-H1 expression exacerbates LPS-induced lung inflammationAttenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation.Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1.Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunctionEndothelial actions of atrial and B-type natriuretic peptidesNovel role of stathmin in microtubule-dependent control of endothelial permeability.Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-AChlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanismsChronic high-magnitude cyclic stretch stimulates EC inflammatory response via VEGF receptor 2-dependent mechanism.The role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels.Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism.Apremilast as a treatment for psoriasis.Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction.Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.cAMP inhibits modulation of airway smooth muscle phenotype via the exchange protein activated by cAMP (Epac) and protein kinase AInvolvement of the Rho kinases in mediating sepsisOpposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.RAGE Plays a Role in LPS-Induced NF-κB Activation and Endothelial Hyperpermeability.P2Y receptors as regulators of lung endothelial barrier integrity.Role of NF-κB activation in LPS-induced endothelial barrier breakdown.Recombinant human brain natriuretic peptide attenuates trauma-/haemorrhagic shock-induced acute lung injury through inhibiting oxidative stress and the NF-κB-dependent inflammatory/MMP-9 pathway.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Substrate stiffness-dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series).Dexmedetomidine alleviates pulmonary edema by upregulating AQP1 and AQP5 expression in rats with acute lung injury induced by lipopolysaccharide.Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
P2860
Q26823225-DCF88456-76ED-4477-9625-E3F4FEFA5B40Q28550936-410C2C33-F3CD-486E-9E41-062152FB2398Q30368379-F78BAB9C-FA4D-4C64-8DFE-5BA162E4DB6EQ30532493-6F7D333A-1BEF-426E-8FD6-B60C67A81BCFQ33756222-3F801968-E9E3-4CDD-BC49-AF2D731CE81CQ33822820-ADCE1D7E-62CC-48E7-B7A3-D40BD3E2A1A6Q34683611-01DFC3AD-8B91-42AC-9B7C-D8B35A3A71DBQ34715709-A12C73CD-5E64-4DAF-AC72-577D222774EEQ34987535-717BD13E-A4A8-46E7-B44C-4F4170EE1BFAQ35138639-032DFFEC-2702-4186-AAE6-B57DBCFB4E24Q35150381-52654EFA-7987-4120-8C0E-869B05790A74Q35207657-17DC14DF-5402-4C4F-B7A0-F4A5C58BD64FQ35214087-2D994F94-7EFB-4916-BCF5-CB5C4843BDDDQ35279340-359C7AAD-626C-4744-B38A-468478A764E0Q35658084-22831D01-97F4-4C27-96A6-731F5FCAED7BQ36159149-EFDCB613-B222-4AEB-B195-E0EA0E5FE8DEQ36183689-4329EA57-EA0C-418E-A72E-222A1CC9AE88Q36599906-62087E61-F404-48AF-BBDA-05EA49D3CC62Q36980301-261964AA-C538-491F-9018-7C415242754AQ37071755-79273312-9D66-4FB7-BF17-7343FF6AB4EBQ37286819-19B31912-FF40-4189-A29B-2E0B3A6DEFFCQ37596383-19CBA9BD-3B4D-445F-A490-CE2D875B0C62Q38019980-FBE88B63-F58E-440A-95CB-D2CDC25B7ABAQ38122283-CDA853A7-4847-4D66-B024-D7FA0A4AC320Q38166604-F6BE4B3B-3DCC-4E74-8843-AC09A47D4FAAQ38770657-677F2536-12AF-4DB8-B392-985A737B043EQ38816005-64CBDC33-19C1-4C5D-985F-5F6AFE3BC30AQ39661770-2E0A22AA-ECA0-48E9-9D90-01681ED87EFAQ40343528-3C8AB5CE-FF48-4B9E-8707-8D0B022F2144Q41078913-ADF18415-3C13-4C29-A83F-A4193197A236Q42285476-0B43360A-61DC-4157-9A42-902E74576520Q42767930-41F978CD-DF2E-4130-8C60-034F90EF1955Q47595764-E716C8CC-E3F7-4E5B-82D8-9416FD7744A4Q47890370-ECD12098-F92E-4C64-B8F1-7660F84FF7D6Q52656382-C9085EF7-40AF-4A90-9CA6-2EDC20729D11Q52715213-32138EB7-4CBF-4EF0-9A5A-7750F87F6334Q53304049-9C15E2E4-4C8C-40D3-AA9C-F598B5667C02Q54445753-DCF31012-7FF8-4697-BA68-C0395CE81A82
P2860
ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@ast
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@en
type
label
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@ast
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@en
prefLabel
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@ast
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@en
P2860
P1476
ANP attenuates inflammatory si ...... y induced by LPS and TNFalpha.
@en
P2093
Anna A Birukova
Junjie Xing
P2860
P356
10.1016/J.MVR.2009.11.006
P577
2009-11-26T00:00:00Z